Tau-associated pathology and brain atrophy in Alzheimer’s disease subtypes

Takeaway

  • There is evidence of frontal cortical involvement of tau pathology in behavioral/dysexecutive Alzheimer’s disease (b/d AD).

Why this matters

  • The b/d AD subtype is characterized by predominant behavioral disinhibition, apathy and/or executive dysfunction on cognitive testing, but differential diagnosis remains an issue due to symptom overlap with frontotemporal dementia (FTT); and studies assessing amyloid-β and tau pathology (known AD markers) in b/d AD are scarce.

  • Frontal cortical tau pathology load in b/d AD may potentially be an early diagnostic biomarker for this subtype; diagnostic markers are crucial for earlier and more accurate diagnosis and ultimately, improvements in clinical care and patients’ quality of life.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.